LA Jolla Institute for ImmunologyFederal contracts and grants
- LA Jolla, CA
- UEI ZPAUY3FQMM26
USAspending shows $163M in obligations to this recipient in 4 of the 5 fiscal years from FY2023 to FY2027.
The obligations in FY2026 were $31M.
Contracts were $6.5M of the obligations in FY2026.
The obligations in FY2027 to date are under $1 million.
The awards of $1 million or more that started since FY2023 came from 1 agency.
The largest award value came from the Department of Health and Human Services.
A fiscal year under $1 million is not in the total.
The states where the work of the awards of $1 million or more is done. The swatches go from the smallest award value to the largest. The largest is California: $56M.
California: the address of the recipient.
The amounts for each state. Outlines: US Census Bureau.
An outlay occurs when federal money is actually paid out, not just promised to be paid ("obligated").
Procurement data (such as for contracts and indefinite delivery vehicles (IDV)) for the Department of Defense (DOD) and U.S. Army Corps of Engineers (USACE) are published on a 90-day delay in the Federal Procurement Data System (FPDS).
Maintaining data quality for the award description field has been persistently challenging for federal agencies.
These are the words of USAspending. Sources: USAspending.gov, About the Data (PDF, last updated 19 November 2025) and USAspending.gov, Glossary. The site copied them on .
The amounts on this page are obligations. An obligation is a promise to pay. It is not a payment. Contract records of the Department of Defense come late, so a recent month can be low. The text under a name in a list of awards is the description that the agency wrote.
USAspending loaded the data on . USAspending profile of this recipient
Since the last update
No change is on record for this page.
The site compares each data load with the load before it. It records a change of the FY2027 obligations when the change is $1 million or more and 10% or more. It also records each new award of $1 million or more.
Obligations by fiscal year
| Fiscal year | All obligations | Contracts | Other awards |
|---|---|---|---|
| FY2023 | $39M | $6.1M | $33M |
| FY2024 | $62M | $6.0M | $56M |
| FY2025 | $31M | $5.2M | $26M |
| FY2026 | $31M | $6.5M | $25M |
| FY2027 to date | under $1 million |
Contracts are the procurement award types. Other awards are grants, direct payments, loans (subsidy cost) and other assistance. The contracts figure shows only when contracts alone are $1 million or more.
Awarding agencies
| Agency | Awards | Award value | Share |
|---|---|---|---|
| Department of Health and Human Services | 11 | $56M | 100% |
Awards
| Awarding agency | Type | Industry or program | Award value | Start date | Place | Record |
|---|---|---|---|---|---|---|
| Department of Health and Human ServicesNational Institutes of Health | ContractDefinitive Contract | 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | $3.6M | 12 Mar 2026 | CA | USAspending |
| Department of Health and Human ServicesNational Institutes of Health | GrantProject Grant (B) | 93.351 Research Infrastructure Programs | $1.7M | 23 Apr 2025 | CA | USAspending |
| Department of Health and Human ServicesNational Institutes of Health | GrantCooperative Agreement (B) | 93.855 Allergy and Infectious Diseases Research | $2.5M | 19 Dec 2024 | CA | USAspending |
| Department of Health and Human ServicesNational Institutes of Health | ContractDefinitive Contract | 541714 Research and Development in Biotechnology (except Nanobiotechnology) | $3.2M | 24 Sep 2024 | CA | USAspending |
| Department of Health and Human ServicesNational Institutes of Health | ContractDefinitive Contract | 541714 Research and Development in Biotechnology (except Nanobiotechnology) | $3.2M | 24 Sep 2024 | CA | USAspending |
| Awarding agency | Type | Industry or program | Award value | Start date | Place | Record |
|---|---|---|---|---|---|---|
| Department of Health and Human ServicesNational Institutes of HealthSTRATEGIC HERPESVIRUS IMMUNE EVASION AND LATENCY DEFENSE (SHIELD) | GrantCooperative Agreement (B) | 93.384 Advanced Research Projects Agency for Health (ARPA-H) | $31M | 27 Aug 2024 | CA | USAspending |
| Department of Health and Human ServicesNational Institutes of HealthIMMUNE EPITOPE DATABASE AND ANALYSIS PROGRAM | ContractDefinitive Contract | 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | $3.6M | 12 Mar 2026 | CA | USAspending |
| Department of Health and Human ServicesNational Institutes of HealthTHE IDENTIFICATION AND VALIDATION OF EPITOPES CONSERVED IN VIRAL PATHOGEN FAMILIES WITH PANDEMIC POTENTIAL | ContractDefinitive Contract | 541714 Research and Development in Biotechnology (except Nanobiotechnology) | $3.2M | 24 Sep 2024 | CA | USAspending |
| Department of Health and Human ServicesNational Institutes of HealthIDENTIFICATION AND CHARACTERIZATION OF T CELL EPITOPES FROM BACTERIAL PATHOGENS CAUSING PNEUMONIA | ContractDefinitive Contract | 541714 Research and Development in Biotechnology (except Nanobiotechnology) | $3.2M | 24 Sep 2024 | CA | USAspending |
| Department of Health and Human ServicesNational Institutes of HealthA NOVEL STRATEGY FOR VACCINE-INDUCED PROTECTION AGAINST MATERNAL-TO-FETAL TRANSMISSION OF ZIKA VIRUS - PROJECT SUMMARY THE LONG-TERM GOAL OF THIS PROJECT IS TO ... | GrantProject Grant (B) | 93.855 Allergy and Infectious Diseases Research | $2.6M | 7 Jun 2024 | CA | USAspending |
| Department of Health and Human ServicesNational Institutes of HealthHIV MRNA VACCINE STRATEGIES FOR EFFICIENT PRIMING, DIVERSITY AND DURABILITY OF IMMUNE RESPONSES - SUMMARY CONVENTIONAL VACCINE STRATEGIES HAVE NOT INDUCED ... | GrantProject Grant (B) | 93.855 Allergy and Infectious Diseases Research | $2.6M | 1 Apr 2024 | CA | USAspending |
| Department of Health and Human ServicesNational Institutes of HealthTOWARDS A PREDICTIVE UNDERSTANDING OF INFLUENZA IMMUNITY THROUGH EXPERIMENTAL DATA INTEGRATION, ITERATIVE MODEL DEVELOPMENT, AND RIGOROUS ASSESSMENT OF MODEL ... | GrantCooperative Agreement (B) | 93.855 Allergy and Infectious Diseases Research | $2.5M | 19 Dec 2024 | CA | USAspending |
| Department of Health and Human ServicesNational Institutes of HealthDYSREGULATION OF TET DIOXYGENASE FUNCTION AS A SOURCE OF ABERRANT TRANSPOSABLE ELEMENT EXPRESSION DURING HUMAN AGING - ABSTRACT IT IS WELL ESTABLISHED THAT ... | GrantCooperative Agreement (B) | 93.855 Allergy and Infectious Diseases Research | $2.0M | 20 Mar 2024 | CA | USAspending |
| Department of Health and Human ServicesNational Institutes of HealthPROTEOME-WIDE BASE EDITOR SCREENS TO ASSESS PHOSPHORYLATION SITE FUNCTIONALITY IN IMMUNOSENESCENCE - ABSTRACT WE OFTEN DEPICT SIGNALING PATHWAYS BY A DOZEN OR ... | GrantProject Grant (B) | 93.396 Cancer Biology Research | $1.7M | 9 Apr 2024 | CA | USAspending |
| Department of Health and Human ServicesNational Institutes of HealthNEXT GENERATION CRISPR READY, HLA CLASS I AND II TRANSGENIC MOUSE PLATFORM - ABSTRACT T CELL RESPONSES ARE CRITICAL IN THE PATHOGENESIS, PREVENTION, AND ... | GrantProject Grant (B) | 93.351 Research Infrastructure Programs | $1.7M | 23 Apr 2025 | CA | USAspending |
| Department of Health and Human ServicesNational Institutes of HealthGENETIC STUDIES LINKING LSP1 FUNCTION IN T CELLS TO INFLAMMATORY BOWEL DISEASE - PROJECT SUMMARY/ABSTRACT INFLAMMATORY BOWEL DISEASES (IBD) CAUSE SUBSTANTIAL ... | GrantProject Grant (B) | 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research | $1.6M | 6 Mar 2023 | CA | USAspending |
Industries, programs and places of performance
| Industry | Awards | Award value |
|---|---|---|
| 541714 Research and Development in Biotechnology (except Nanobiotechnology) | 2 | $6.4M |
| 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | 1 | $3.6M |
| Assistance listing | Awards | Award value |
|---|---|---|
| 93.384 Advanced Research Projects Agency for Health (ARPA-H) | 1 | $31M |
| 93.855 Allergy and Infectious Diseases Research | 4 | $9.7M |
| 93.396 Cancer Biology Research | 1 | $1.7M |
| 93.351 Research Infrastructure Programs | 1 | $1.7M |
| 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research | 1 | $1.6M |
| State | Awards | Award value |
|---|---|---|
| California | 11 | $56M |
The counties with the largest award value, largest first.
Other recipients of about the same size
Recipients in NAICS 541714, Research and Development in Biotechnology (except Nanobiotechnology), with an address in California. In order of name. These recipients have obligations nearest to those of LA Jolla Institute for Immunology in the listed fiscal years.
- 4J Therapeutics IncPalo Alto, CA
- Aptitude Medical Systems IncGoleta, CA
- Cerus CorporationConcord, CA
- Chromologic LLCMonrovia, CA
- Cidara Therapeutics IncSan Diego, CA
- Eitr Biologics, Inc.San Diego, CA
- Genentech IncSouth San Francisco, CA
- Mapp Biopharmaceutical, Inc.San Diego, CA
- Ossium Health, Inc.San Francisco, CA
- Personalis, Inc.Menlo Park, CA
- The Leland Stanford Junior UniversityStanford, CA
- University of California, San DiegoLA Jolla, CA
All recipients in California, in order of name.
Official records
- USAspending profile of this recipientUSAspending.gov. The official record of the awards to this recipient (UEI ZPAUY3FQMM26).
- SAM.gov entity searchSAM.gov, U.S. General Services Administration. The search of entity registrations by name or UEI.
- USAspending advanced searchUSAspending.gov. The search of all award records, with filters for recipient, agency, place and time period.
Each link opens a page of a federal agency in a new tab. The site examined the links on .
Cite this page
Fed Spend Map. "LA Jolla Institute for Immunology: federal contracts and grants". Data: USAspending.gov, U.S. Department of the Treasury, Bureau of the Fiscal Service, loaded .
https://fedspendmap.com/recipient/zpauy3fqmm26-la-jolla-institute-for-immunology/
The address of this page is permanent.
Where the figures come from
USAspending.gov API v2 (U.S. Department of the Treasury, Bureau of the Fiscal Service). Fiscal year obligations: the list of recipients by state, with a listing floor of $1 million for each year. Awards: the award search, new awards of $1 million or more by base obligation date. Parent and business types: the recipient profile.
USAspending loaded the data on 30 Sep 2026. A closed fiscal year is a copy made after the year end. The site shows organisations only. The site corrects an error in its own work at the next build. See how to report an error and how the atlas is made.
Questions
Which fiscal years are in the total?
The total has 4 fiscal years.
- FY2023: $39M
- FY2024: $62M
- FY2025: $31M
- FY2026: $31M
- FY2027 to date: under $1 million
The site lists a fiscal year of a recipient when the obligations of the year are $1 million or more.
Which industries and programs do the awards name?
The contract awards of $1 million or more name 2 NAICS industries.
The largest award value is in NAICS 541714, Research and Development in Biotechnology (except Nanobiotechnology): $6.4M.
The assistance awards name 5 assistance listings.
The largest award value is in listing 93.384, Advanced Research Projects Agency for Health (ARPA-H): $31M.
Where is the place of performance?
The awards of $1 million or more name 1 state as the place of performance.
The largest award value is in California: $56M.
The place of performance is where the work is done. It is not always the address of the recipient.
How many awards are in the lists on this page?
The lists hold 11 awards of $1 million or more that started in FY2023 or later.
Their award value is $56M.
An award under that amount is in the obligations of the fiscal years but not in the lists.